Fresh Equities
Raises
Markets
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

ASX:CDY logo

ASX:CDY

Cellmid Limited

Health Care / Biotechnology

Current price

$0.063

0.001 (1.56%)

Last trade: Invalid date GMT

Market cap

$11.81m

20 min delay

Investor Presentations

Principal Activity

Cellmid Limited (CDY) is an Australian life sciences company with lead programs in multiple disease indications. The Company, through its wholly owned subsidiaries, Lyramid, Kinera and Advangen, develops and markets in novative novel therapies and diagnostic tests for fibrotic diseases, cancer, ischemic diseases of the heart and hair loss. They operate through two business segment Midikine and Consumer health.


Address

Suite 204, Level 2/55 Clarence St, Sydney NSW 2000, Australia

News

Announcements

Filter

All categories
Investor Presentations
Trading Halt
Qtly Cashflow
Issued Capital
Periodic Reports
AnnouncementT+2 MovementDate

Rows per page:

5

0-0 of 0

Market Data

Day

3m

1yr

5yr

Current price

$0.063

Open price

-

Day low-high

-

Price change

-

Percent change

-

Previous close

-

Volume

-

Turnover

-

Bid price

-

Ask price

-

Market cap

-

Shares outstanding

-

Year high

-

Year low

-

Year low-high

-

Earnings per share

-

Price/earnings ratio

-

Dividend yield

-

Dividend per share

-

Franking

-

Investor Presentations

News

Sector Peers

CompanyMarket Cap
Fresh Equities
App Store
Play Store

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 19, 15 William St
Melbourne VIC 3000
Australia

App Store
Play Store

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.